Oncology Today with Dr Neil Love
Chronic Lymphocytic Leukemia — Microlearning Activity 1
· 25 min · Stagione 26 Episodio 360
Note dell’episodio
Featuring perspectives from Dr Catherine C Coombs, including the following topics:
• Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL) (0:00)
• Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor therapy in CLL; minimal residual disease and disease monitoring (4:10)
• Ongoing Phase III trials of BTK inhibitor/B-cell lymphoma 2 inhibitor combinations in previously untreated CLL (10:05)
• Pirtobrutinib as first-line therapy for CLL and long-term safety data (15:22)
CME information and select publications
Sito web: oncologytoday.captivate.fm
